Benefits of leptin therapy in HIV patients

Autor Sinha, Uma, Sinharay, Keshab, Sengupta, Nilanjan, Mukhopadhyay, Prasanta
Vydáno 2012

SUN-098 Low-Dose Infigratinib Treatment Does Not Lead to Changes in Phosphorous Preclinically in Mice

Autor Reyes, Maribel, Sinha, Uma, Li, Gary, Martin, David
Vydáno v J Endocr Soc (2020)

Human immunodeficiency virus endocrinopathy

Autor Sinha, Uma, Sengupta, Nilanjan, Mukhopadhyay, Prasanta, Roy, Keshab Sinha
Vydáno 2011

Acromegaly without acral changes: A rare presentation

Autor Sengupta, Nilanjan, Sinha, Uma, Roy, Keshab Sinha, Saha, Sudipta
Vydáno 2012

Recurrent hypokalemic paralysis: An atypical presentation of hypothyroidism

Autor Sinha, Uma, Sengupta, Nilanjan, Sinharay, Keshab, Sahana, Pranab K.
Vydáno 2013

Src Family Kinases and Syk Are Required for Neutrophil Extracellular Trap Formation in Response to β-Glucan Particles

Autor Nanì, Sara, Fumagalli, Laura, Sinha, Uma, Kamen, Lynn, Scapini, Patrizia, Berton, Giorgio
Vydáno v J Innate Immun (2014)

Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India

Autor Sinha, Uma, Sinharay, Keshab, Saha, Sudipta, Longkumer, T. Amenla, Baul, Shuvra Neel, Pal, Salil Kuamr
Vydáno 2013

Methotrexate and a spleen tyrosine kinase inhibitor cooperate to inhibit responses to peripheral blood B cells in rheumatoid arthritis

Autor Coffey, Greg, Betz, Andreas, Graf, Jonathan, Stephens, Gillian, Hua Lin, Pei, Imboden, John, Sinha, Uma
Vydáno 2013

Critical Role for an Acidic Amino Acid Region in Platelet Signaling by the HemITAM (Hemi-immunoreceptor Tyrosine-based Activation Motif) Containing Receptor CLEC-2 (C-type Lectin R...

Autor Hughes, Craig E., Sinha, Uma, Pandey, Anjali, Eble, Johannes A., O'Callaghan, Christopher A., Watson, Steve P.
Vydáno 2013

Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)

Autor Connolly, Stuart J., Eikelboom, John, Dorian, Paul, Hohnloser, Stefan H., Gretler, Daniel D., Sinha, Uma, Ezekowitz, Michael D.
Vydáno 2013

First‐in‐Human Study of AG10, a Novel, Oral, Specific, Selective, and Potent Transthyretin Stabilizer for the Treatment of Transthyretin Amyloidosis: A Phase 1 Safety, Tolerability...

Autor Fox, Jonathan C., Hellawell, Jennifer L., Rao, Satish, O'Reilly, Terry, Lumpkin, Rick, Jernelius, Jesper, Gretler, Daniel, Sinha, Uma
Vydáno v Clin Pharmacol Drug Dev (2019)

Synergistic induction of tissue factor by coagulation factor Xa and TNF: Evidence for involvement of negative regulatory signaling cascades

Autor Hezi-Yamit, Ayala, Wong, Paul W., Bien-Ly, Nga, Komuves, Laszlo G., Prasad, K. S. Srinivasa, Phillips, David R., Sinha, Uma
Vydáno 2005

Heparin rescues factor V Leiden–associated placental failure independent of anticoagulation in a murine high-risk pregnancy model

Autor An, Jianzhong, Waitara, Magarya S., Bordas, Michelle, Arumugam, Vidhyalakshmi, Hoffmann, Raymond G., Petrich, Brian G., Sinha, Uma, North, Paula E., Sood, Rashmi
Vydáno 2013

PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy Volunteers

Autor Coffey, Greg, Rani, Aradhana, Betz, Andreas, Pak, Yvonne, Haberstock‐Debic, Helena, Pandey, Anjali, Hollenbach, Stanley, Gretler, Daniel D., Mant, Tim, Jurcevic, Stipo, Sinha, Uma
Vydáno v J Clin Pharmacol (2016)

Selective, novel Spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B cell activation and migration

Autor Hoellenriegel, Julia, Coffey, Greg P., Sinha, Uma, Pandey, Anjali, Sivina, Mariela, Ferrajoli, Alessandra, Ravandi, Farhad, Wierda, William G., O’Brien, Susan, Keating, Michael J., Burger, Jan A.
Vydáno v Leukemia (2012)

PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model

Autor Reilly, Michael P., Sinha, Uma, André, Pierrette, Taylor, Scott M., Pak, Yvonne, DeGuzman, Francis R., Nanda, Nisha, Pandey, Anjali, Stolla, Moritz, Bergmeier, Wolfgang, McKenzie, Steven E.
Vydáno 2011

Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa

Autor Siegal, Deborah, Lu, Genmin, Leeds, Janet M., Karbarz, Mark, Castillo, Janice, Mathur, Vandana, Hutchaleelaha, Athiwat, Sinha, Uma, Kitt, Michael, McClure, Matt, Hollenbach, Stanley J., Curnutte, John T., Conley, Pamela B., Crowther, Mark
Vydáno v Blood Adv (2017)

The Selective Syk Inhibitor P505-15 (PRT062607) Inhibits B Cell Signaling and Function In Vitro and In Vivo and Augments the Activity of Fludarabine in Chronic Lymphocytic Leukemia

Autor Spurgeon, Stephen E., Coffey, Greg, Fletcher, Luke B., Burke, Russell, Tyner, Jeffrey W., Druker, Brian J., Betz, Andreas, DeGuzman, Francis, Pak, Yvonne, Baker, Dale, Pandey, Anjali, Hollenbach, Stanley J., Sinha, Uma, Loriaux, Marc M.
Vydáno 2013

Enthalpy-driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis

Autor Miller, Mark, Pal, Arindom, Albusairi, Wabel, Joo, Hyun, Pappas, Beverly, Tuhin, Md Tariqul Haque, Liang, Dengpan, Jampla, Raghavendra, Liu, Fang, Khan, Jared, Faaij, Marjon, Park, Miki, Chan, William, Graef, Isabella, Zamboni, Robert, Kumar, Neil, Fox, Jonathan, Sinha, Uma, Alhamadsheh, Mamoun
Vydáno v J Med Chem (2018)

Critical role for Syk in responses to vascular injury

Autor Andre, Patrick, Morooka, Toshifumi, Sim, Derek, Abe, Keith, Lowell, Clifford, Nanda, Nisha, Delaney, Suzanne, Siu, Gail, Yan, Yibing, Hollenbach, Stan, Pandey, Anjali, Gao, Huiyun, Wang, Yunmei, Nakajima, Kohsuke, Parikh, Sahil A., Shi, Can, Phillips, David, Owen, Whyte, Sinha, Uma, Simon, Daniel I.
Vydáno 2011